Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 4, 2008, Pages 292-297

  Kushi, Hidehiko ^a,b   Miki, Takahiro ^a   Sakagami, Yuichiro ^c   Saito, Takeshi ^a,b   Tanjoh, Katsuhisa ^b  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CSL Behring KK   (Japan)

Author keywords

Hemoperfusion; Immobilized polymyxin B fiber column; Oxygen consumption index; Oxygen delivery index; Sepsis

Indexed keywords

OXYGEN; POLYMYXIN B;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOPERFUSION; HUMAN; MALE; MEDICAL INSTRUMENTATION; METABOLISM; OXYGEN CONSUMPTION; OXYGEN SATURATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; TREATMENT RESPONSE; VASCULAR RESISTANCE; VENOUS OXYGEN TENSION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD PRESSURE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; POLYMYXIN B; RETROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TIME FACTORS;

EID: 49249100740     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00590.x     Document Type: Article

References (25)

1. Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome. The Japanese experience. Ther Apher Dial 2003 7: 252 8.
2. Kushi H, Nakahara J, Miki T et al. Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells. Ther Apher Dial 2005 9: 303 7.
3. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Hemoperfusion with an immobilized polymyxin B fiber column reduces the blood level of neutrophil elastase. Blood Purif 2006 24: 212 17.
4. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005 9: R653 61.
5. Kushi H, Miki T, Nakahara J et al. Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentration. Ther Apher Dial 2006 10: 425 9.
6. Kushi H, Miki T, Nakahara J et al. Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism. Ther Apher Dial 2006 10: 430 5.
7. Tani T, Hanasawa K, Kodama M et al. Correlation between plasma endotoxin, plasma cytokine, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001 25: 660 8.
8. Nemoto H, Makamoto H, Okada H et al. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001 19: 361 9.
9. Uriu K, Osajima A, Kamochi M, Watanabe H, Aibara K, Kaizu K. The severity of hyperdynamic circulation may predict the effect of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock. Ther Apher Dial 2001 5: 25 30.
10. Vincent JL, Laterre PF, Cohen J et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005 23: 400 5.
11. Shoemaker WC, Appel PL, Kram HB. Role of oxygen debt in the development of organ failure sepsis, and death in high risk surgical patients. Chest 1992 102: 208 15.
12. Rackow EC, Astiz ME, Weil MH. Cellular oxygen metabolism during sepsis and shock. JAMA 1988 256: 1989 93.
13. Abraham E, Bland RD, Cobo JC, Shoemaker WC. Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest 1984 85: 75 80.
14. Shoemaker WC, Apple PL, Kram HB, Waxman K, Lee TS. Prospective trial of supernormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1998 10: 1176 86.
15. Hauser CJ, Lewis FR. Is supranormal oxygen delivery beneficial? Pro and Con. In: Deitch EA, Vincent JL, Windsor A, eds. Sepsis and Multiple Organ Dysfunction: a Multidisciplinary Approach. London, Edinburgh, New York, Philadelphia, St Louis, MO, Sydney, Toronto: W.B. Saunders, 2002 238 47.
16. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure for the use of innovative therapies in sepsis. Chest 1992 101: 1644 55.
17. Vincent JL, Mendonca A, Cantraine F et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care unit: results of a multicenter, prospective study. Crit Care Med 1998 26: 1793 800.
18. Knaus WA, Draper EA, Wanger DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985 13: 818 20.
19. Chen HW, Hsu C, Lu TS, Wang SJ, Yang RC. Heat shock pre-treatment prevents cardiac mitochondrial dysfunction during sepsis. Shock 2003 20: 274 49.
20. Vandermeer TJ, Wang H, Fink M. Endotoxaemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995 23: 1217 26.
21. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993 41: 1343 50.
22. Brealey D, Brand M, Hargreaves I et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002 360: 219 23.
23. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not its precursor, nitric oxide. J Biol Chem 1994 269: 29409 15.
24. Marie RV, Cornejo C. Neutrophil-Endothelial Interactions. In: Vincent LJ, Deitch E, Windsor A, eds. Sepsis, and Multiple Organ Dysfunction: a Multidisciplinary Approach. London: WB Saunders, 2002 95 104.
25. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999 342: 586 92.